News Konvomep Approved for Active Benign Gastric Ulcer, Upper GI Bleed Risk Reduction Publish Date September 6, 2022 Konvomep contains 2mg of omeprazole, a proton pump inhibitor, and 84mg of sodium bicarbonate per mL after reconstitution.
News New Tablet Formulation of Calquence Approved for CLL, SLL, MCL Publish Date August 5, 2022 The approval was based on data from the phase 1 ELEVATE-PLUS trials, which showed the acalabrutinib 100mg tablets were bioequivalent to the acalabrutinib 100mg capsules.